|
ADMA ADMA Biologics Inc 1368514 |
| Balance Sheet |
|
Current Assets
|
$511,173,000.00 |
|
Assets
|
$665,184,000.00 |
|
Current Liabilities
|
$73,541,000.00 |
|
Liabilities
|
$274,859,000.00 |
|
Equity
|
$390,325,000.00 |
|
Shares Out
|
232288977.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$58,249,000.00 |
|
Investing Cash Flow
|
$2,404,000.00 |
| Market Analysis |
Market Cap
|
$2,013,945,430.59 |
|
Price
|
$8.70 |
|
BVPS
|
1.68 |
|
PB
|
5.16 |
|
EPS
|
0.19 |
|
PE
|
12.90 |
|
PS
|
4.54 |
|
FCF
|
$55,706,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:22 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:18 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-25 |
0.20 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-06 |
0.19 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
0.14 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
0.15 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ADMA documents filed with the SEC.
ADMA Filings
Clear
